Skip to main content
. 2020 Jan 13;15:1. doi: 10.1186/s13722-020-0179-8

Table 1.

LINC-II eligibility criteria

Inclusion criteria Exclusion criteria
Age 18 years or older Not fluent in Russian
HIV-positive Cognitive impairment precluding informed consent
Hospitalized at narcology hospital Breastfeeding or being pregnant
History of injection drug use ART use in the past 30 days prior to hospitalization
Provision of two contacts to assist with follow-up Acute severe psychiatric illness (i.e., answered yes to any of the following: past three month active hallucinations; mental health symptoms prompting a visit to the emergency room or hospital; mental health medication changes due to worsening symptoms; presence of suicidal ideations)
Address within St. Petersburg or districts within 100 km of St. Petersburg Known history of liver failure
Possession of a home or mobile phone Known hypersensitivity to naltrexone
Ability and willingness to comply with all study protocols and procedures Aspartate aminotransferase (AST) or alanine aminotransferase (ALT) greater than 5 times the upper limit of normal
Severe thrombocytopenia
Known coagulation disorder/taking anticoagulation medications
Body habitus that precludes intramuscular injection (e.g., BMI < 17 or > 45)
Known history of Raynaud’s disease, Itsenko-Cushing syndrome, generalized mycoses, glaucoma, or osteoporosis
Planned surgeries in the next 12 months